 |
Recombinant P-Selectin glycoprotein ligand |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of delayed graft function in renal transplant patients |
| USA Market Approval | USA |
| USA Designation Date | 2006-03-29 00:00:00 |
| Sponsor | Y's Therapeutics, Inc.;1111 Bayhill Drive, Suite 405;San Bruno, California, 94066 |
